PandaOmics
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base; also answers literature-review questions through ChatPandaGPT.
Find alternatives to PandaOmics
What it does
- Drug discovery
- Data analysis
- Knowledge retrieval
Features 7
- Target IDAI prioritizes disease target genes by novelty, safety and existing drugs, refinable with in-house Omics data.
- Target EvaluationSystematically evaluates molecular and text evidence connecting a target and a disease.
- Target Attention PredictionEvaluates how interest in a gene changes over the years and forecasts attention growth.
- Omics Data AnalysisNormalized, annotated Omics collections for target, indication and compound prioritization and differential expression.
- Pathway AnalysisFinds molecular processes affected by disease using the proprietary iPanda algorithm.
- Biological Knowledge GraphVisualizes relevant scientific papers in a knowledge graph, with ChatPandaGPT for literature questions.
- Gene-Disease Association ReportSummarizes papers, Omics evidence, mechanism of action, competitive landscape and path to market in one report.
Sources
- Pricing
-
Official documentation · 3 Sep 2026
Academic price quoted on the product page; no full pricing page exists in https://pharma.ai/sitemap.xml.
- Constraints
-
Official documentation · 2 Oct 2026
Derived from the security facts on this page, from the same source.
- Security
-
Official documentation · 2 Oct 2026
Company-wide Security & IT page covering client data and IP across engagements, applied to all listed products (page names none individually). ISO 27001 refers to the ISMS. Residency is client-chosen cloud servers, recorded as custom. Training, ZDR, DPA not stated.
- Sold within
-
Official documentation · 15 Sep 2026
pharma.ai/pandaomics (already cited official-docs elsewhere on this record); standalone technology access or bundled with Pharma.ai collaborations, i.e. no restriction.
- Modalities
-
Official documentation · 1 Oct 2026
Page: 'Upload your in-house Omics data to refine the ranking. / Summarize all relevant information about gene-disease association into a comprehensive report'.
- Intended for
-
"$199 per month for Academia!" pricing tier; testimonial from "Vice President of Digital Technology at the Indiana Biosciences Research Institute".
Also from Insilico Medicine
-
Pharma.AI Platform
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
-
PandaOmics Box Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
-
Chemistry42 Platform
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
-
Biology42: Generative Biologics Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
-
inClinico Application
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
-
Science42: DORA Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
-
MMAI Gym Platform
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
Open Insilico Medicine in the directory
Something wrong here? Send a correction — quote this product id: insilico-medicine-pandaomics.